Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising pharmaceuticals. The company has a track record of innovation and success in developing new oral drug delivery systems.

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

MYX

COM:MAYNEPHARMA

Mayne Pharma

Last Close

4.43

08/11 05:10

Market Cap

362.42M

Beta: -

Volume Today

381.98K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics